Grikli PG 2mg/500mg/15mg Tablet
Marketer
Prector Lifesciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Grikli PG 2mg/500mg/15mg Tablet
TriComb 2/500/15 Tablet is a triple-action formulation designed to manage blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen for TriComb 2/500/15 Tablet. Administer with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, omit the missed dose and resume the usual schedule. Never double the dose. An overdose can cause hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol, or skipped meals may increase hypoglycemia risk. Regular blood sugar monitoring is essential. Common adverse events include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or cardiac issues to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function assessment will be conducted before treatment initiation. Limit alcohol consumption as it may heighten the risk of side effects.
Primary Ingredients of Grikli PG 2mg/500mg/15mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Grikli PG 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Grikli PG 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Grikli PG 2mg/500mg/15mg Tablet with a meal.
Common Side effects of Grikli PG 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Grikli PG 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Grikli PG 2mg/500mg/15mg tablets should be administered with a meal.
How Grikli PG 2mg/500mg/15mg Tablet works:
Grikli PG 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions—to optimize blood sugar management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Grikli PG 2mg/500mg/15mg Tablet with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Grikli PG 2mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of Grikli PG 2mg/500mg/15mg tablets are likely incompatible. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar fluctuations.
KidneyCAUTION
Exercise caution when administering Grikli PG 2mg/500mg/15mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. The use of Grikli PG 2mg/500mg/15mg tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Grikli PG 2mg/500mg/15mg Tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. The use of Grikli PG 2mg/500mg/15mg Tablets is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Grikli PG 2mg/500mg/15mg Tablet :
Should you forget to take a Grikli PG 2mg/500mg/15mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Grikli PG 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently